Chobi Company Limited Overview
Chobi is one of the oldest compound-fertilizer manufacturers in South Korea. It was founded in 1955 and has belonged to the agrochemical group around Kyung Nong Corporation, part of the Dong-O group of companies. The company produces and distributes a broad range of compound and specialty fertilizers: basal and top-dressing compound fertilizers for rice, horticulture and fruit trees, bulk-blending (BB) fertilizers, controlled-release fertilizers (CRF) such as its "Danhanbeon" brand, fertigation, hydroponic and liquid fertilizers, and organic products. It holds licences for roughly 670 fertilizer products [S12].
Distribution relies heavily on the Nonghyup (NH) agricultural-cooperative procurement system, and the company held about a 9.7% share of the Korean fertilizer market at end-2021 [S9]. Chobi is small, with KRW 99.7bn revenue and about 107 employees. It is domestically focused, carries short-term debt and shows thin, volatile margins. Its points of difference are a long-established brand with NH, plants in Ulsan, Andong, Cheonan and Yeongdong, and a nascent biodegradable-coating CRF franchise developed with KRICT and Aekyung Chemical.
What the company does
Chobi manufactures and sells fertilizers. Raw nutrients, mainly imported nitrogen, phosphate and potash materials, are granulated, blended, coated or formulated into finished products for Korean agriculture, horticulture, forestry and turf.
Morningstar's profile, drawn from company filings, describes the range as:
-
top-dressing compound fertilizers for horticulture, fruit trees and paddy rice;
-
bulk-blending fertilizers;
-
basal compound fertilizers for tobacco, peanuts, vegetables, garlic and onions, fruit trees, chestnuts, rice seedbeds, paddy rice, potatoes and turf [S29].
Other profiles add controlled-release compound fertilizers, fertigation compounds, sul-po-mag (sulphate of potash-magnesia), hydroponic compounds, liquid fertilizers, MCF organic fertilizers and "PNS CRF" fertilizers [S30][S31].
Company's own description (paraphrased from filings and quarterly report commentary)
In its Q1 2022 quarterly report, cited by Asia Economy, Chobi described the industry as follows:
-
After two rounds of government-led industry rationalisation, about eight companies manufacture and sell fertilizers in Korea.
-
Chobi held about 9.7% of the overall fertilizer market at end-2021.
-
Its main products include controlled-release fertilizers such as "Danhanbeon" (단한번).
-
A large portion of its sales goes through the National Agricultural Cooperative Federation (NH) [S9].
A Korean investor data source summarises the company as a fertilizer maker founded on 15 November 1955 with private capital. Its stated purposes were the scientific modernisation of agriculture, soil improvement and production of quality fertilizers, and it listed on the securities market in 1976 [S12].
Business and revenue model
| Dimension | Characterisation | Basis |
|---|---|---|
| Revenue type | Almost entirely product sales. In Q2 2026, manufactured fertilizer was 88% of revenue, traded (merchandise) fertilizer 4% and other 8% | [S7] |
| Service / subscription / licensing | None identified | — |
| Value-chain position | Mid-stream formulator and blender. Buys imported or domestic primary nutrients (urea, ammonium phosphates, potassium chloride and similar) and converts them into compound and specialty finished goods | [S1][S9]; analyst characterisation |
| Primary channel | NH procurement (Nonghyup Economic Holdings, formerly the NH Central Federation), which resells to farmers through local cooperatives | [S9][S17][S18] |
| Secondary channels | Commercial/retail market (시판), specialty horticulture and turf; small exports, e.g. biodegradable CRF to an Indonesian palm plantation | [S16]; analyst characterisation |
| Customer types | Korean farmers (rice, horticulture, fruit, tobacco, vegetables); forestry; turf/golf; plantation agriculture (export) | [S29][S13] |
| Seasonality | Strong. Revenue and profit peak in Q1–Q2 with spring application; Q3–Q4 are typically loss-making | [S3] |
End-markets served
-
Paddy rice: basal, top-dressing and controlled-release fertilizers, including one-shot application products such as Danhanbeon.
-
Horticulture and protected cultivation: compound, fertigation, hydroponic and liquid fertilizers.
-
Fruit trees and chestnuts: dedicated compound fertilizers.
-
Industrial crops: tobacco and peanut compound fertilizers.
-
Forestry and turf: forestry-use and turf fertilizers [S13][S29].
-
Export plantation agriculture: biodegradable CRF shipped to POSCO International's palm plantation in Indonesia (PT BIA) from July 2024 [S16].
Independent characterisation
Chobi is a price-taker on inputs and a quasi-regulated seller on outputs. Its procurement costs move with global nitrogen, phosphate and potash prices and the KRW/USD rate. Much of its output is sold under NH supply contracts, where pricing is negotiated and volumes depend on NH's offtake. A 2021 contract filing stated explicitly that contracted quantities may change with NH's actual intake [S17].
As a result, gross margin depends on the timing between input-cost moves and NH price resets. This pattern is visible in FY2022 (windfall), FY2023 (inventory-cost squeeze, 9.5% gross margin) and FY2024–25 (normalisation at about 21%) [S1].
Strategically, the company is trying to move up the value chain into controlled-release and environmentally differentiated products, notably biodegradable bio-urethane coatings, where product differentiation can support better pricing than commodity blends [S14][S15].
Strategy
Stated corporate strategy
Chobi does not publish investor-day material, medium-term plans or an English-language strategy statement. No corporate value-up plan under the Korea Exchange Value-Up programme was identified for Chobi. Its peer Hyosung ONB filed one on 30 September 2026 [S25].
Strategic themes evident from disclosures and partner releases:
-
Shift toward controlled-release and eco-friendly fertilizers. KRICT says Chobi plans to keep improving the bio-urethane CRF and expand market share [S14]. The joint aim with Aekyung Chemical is to raise soil biodegradability of CRF coatings and reduce environmental contamination [S15].
-
Anchor relationship with NH procurement. Recurring NH inorganic-fertilizer contracts were KRW 81.8bn in 2010 and KRW 58.76bn in 2021 [S17][S18]. A recruitment-research profile says Chobi has held continuous supply contracts with NH Economic Holdings since 2020 [S13].
-
Selective export development through partnership with a trading house, POSCO International, rather than building its own overseas sales [S16].
Initiatives in the last 24 months (Oct 2024 – Oct 2026)
| Date | Initiative | Type | Detail | Source |
|---|---|---|---|---|
| Jul 2024 (just outside window; ongoing) | Biodegradable CRF exports to Indonesia | Market expansion | Supplied to POSCO International's PT BIA palm plantation | [S16] |
| 2021 onward (recognised Aug 2025) | Bio-urethane coated CRF | Product / technology | KRICT-assisted; more than KRW 10bn facility investment; KRW 10.9bn sales in 2023 | [S14] |
| Nov 2023 onward | Biodegradable-resin CRF with Aekyung Chemical | R&D partnership | Aekyung develops the resin, Chobi manufactures the finished CRF | [S15] |
| 2,026 | Governance reporting | ESG / governance | Corporate Governance Report filed in May 2026 and amended in September 2026 | [S7] |
No transformation programmes, cost-reduction programmes with quantified targets, new business launches or sustainability commitments with targets were identified.
Management guidance
None. Chobi does not issue financial guidance or medium-term targets.
Products & Services
Chobi holds production licences for about 670 fertilizer products [S12]. Individual SKU-level specifications, launch years and list prices are generally not publicly disclosed. The catalogue below is reconstructed from filings excerpts, aggregator profiles and press. Where a price is shown, it is the average price per metric tonne reported in the company's periodic report.
Controlled-release and coated fertilizers (CRF)
| Product / line | Description | Target customer | Pricing data | Source |
|---|---|---|---|---|
| Danhanbeon (단한번) — flagship | Controlled-release fertilizer; the name means "just once", signalling a single application per season | Paddy-rice and field-crop farmers via NH | Average price rose from KRW 835,583/t to KRW 1,205,383/t (+44.3%) between the prior year and Q1 2022 | [S9] |
| Bio-urethane coated CRF (KRICT co-development) | CRF coated with a bio-based polyurethane made from plant-oil-derived polyols, designed to degrade fully in soil and avoid microplastic residue from petroleum-based coatings | Farmers and institutions seeking eco-friendly CRF | Not disclosed; contributed KRW 10.9bn of sales in 2023 | [S14] |
| Biodegradable-resin CRF (Aekyung Chemical co-development) | CRF coated with a biodegradable resin supplied by Aekyung Chemical; an earlier plant-oil-based coating resin carries USDA bio-based certification | Domestic market; export to POSCO International's PT BIA palm plantation, Indonesia | — | [S15][S16] |
| PNS CRF fertilizers | Controlled-release product line named in company profiles | — | — | [S30] |
Compound fertilizers (basal and top-dressing)
| Product / line | Description | Target crops | Pricing data | Source |
|---|---|---|---|---|
| Euttum NK 18-0-16 (으뜸NK 18-0-16) | Nitrogen–potassium top-dressing compound (N 18%, K₂O 16%) | Rice and horticulture | Average price rose 113.89% (prior year → Q1 2022) | [S9] |
| Ipyeonhan S (이편한S) | Compound fertilizer product | — | Average price rose 99.35% (prior year → Q1 2022) | [S9] |
| Customised fertilizer (맞춤형비료) | Soil-test-based blended fertilizers procured via NH | Region- and crop-specific programmes | Average price rose 125.19% (prior year → Q1 2022) | [S9] |
| Top-dressing compound fertilizers | Compounds applied during growth | Horticulture, fruit trees, paddy rice | — | [S29] |
| Basal compound fertilizers | Compounds applied before or at planting | Tobacco, peanuts, vegetables, garlic and onions, fruit trees, chestnuts, rice seedbeds, paddy rice, potatoes, turf | — | [S29] |
| Crop-specific lines (tobacco, rice, fruit, forestry) | Purpose-formulated compounds | Tobacco growers, rice, orchards, forestry | — | [S13] |
Bulk-blending and straight-nutrient products
| Product / line | Description | Source |
|---|---|---|
| Bulk-blending (BB) fertilizers | Physical blends of granular nutrients | [S29][S31] |
| Sul-po-mag | Potassium–magnesium sulphate fertilizer | [S31] |
Water-soluble, fertigation and hydroponic fertilizers
| Product / line | Description | Target customer | Source |
|---|---|---|---|
| Fertigation compound fertilizers | Water-soluble compounds delivered through irrigation | Protected horticulture | [S31] |
| Hydroponic (hydroponix) compound fertilizers | Complete-nutrient formulations for soilless cultivation | Hydroponic and smart-farm growers | [S30][S31] |
| Liquid fertilizers | Liquid nutrient formulations | Horticulture | [S31] |
Organic fertilizers
| Product / line | Description | Source |
|---|---|---|
| MCF organic fertilizers | Organic fertilizer line | [S30] |
Merchandise and other
Traded fertilizers (상품): 4% of Q2 2026 revenue; specific products not disclosed [S7].
Other revenue: 8% of Q2 2026 revenue; composition not disclosed [S7].
Launch years and versioning: Not publicly disclosed for the core range. The bio-urethane CRF was commercialised by 2023 [S14]. The Aekyung biodegradable CRF was in market before November 2023 and exported from July 2024 [S15][S16].
Financial Narrative
All annual figures are separate K-IFRS figures for fiscal years ending 31 December, in KRW billions unless stated. Income-statement data come from DART business reports via [S1] and [S8]. FY2025 line items come from [S5]. Balance-sheet data come from [S4]. Cash-flow data come from [S6] (FY2025) and [S8] (FY2021–FY2024 operating cash flow).
Income statement
Notes:
-
Diluted EPS is shown equal to basic.
-
DPS of zero reflects aggregator data showing no cash dividends (0.00% yield, no dividend payments in cash-flow data) [S1][S6][S32]. It should be confirmed against DART dividend disclosures.
-
Pre-tax income and tax for FY2021–FY2024 were not available in the sources reviewed.
-
Aggregators differ on FY2025 EBITDA: KRW 5.6bn per [S1] versus KRW 6.55bn per [S5]. The difference reflects different depreciation definitions; [S1] is used for consistency.
Margin profile
Source: [S1].
Revenue CAGR (analyst-computed):
-
FY2021–FY2025 (four years): +4.2% a year.
-
FY2020–FY2025 (five years, from FY2020 revenue of KRW 73.7bn [S1]): +6.2% a year.
FY2025 cost structure detail
Source: [S5] (DART FY2025 business report as reproduced by ValueLine).
Raw materials account for about 95% of cost of sales, which shows how directly the business is exposed to fertilizer-input commodity prices.
Quarterly trajectory (seasonality)
Source: [S3].
-
Q2 2024 and Q3 2024 are analyst-derived from reported 2025 YoY growth rates and FY2024 totals.
-
Q4 2025 is analyst-derived as FY2025 minus Q1–Q3 2025.
-
Rounding differences of ±0.1bn are possible.
1H26 versus 1H25 (KRW bn):
-
Revenue: 90.0 versus 74.4 (+21%).
-
Operating income: 8.5 versus 7.1 (+20%).
-
Net income: 6.9 versus 6.3 (+10%).
Trailing twelve months to June 2026:
-
Revenue: KRW 115.4bn.
-
Operating income: KRW 5.23bn.
-
Net income: KRW 2.55bn.
-
EPS: KRW 493.
Sources: [S3][S5].
Balance sheet
Source: [S4].
-
FY2021 balance-sheet data were not available in the sources reviewed.
-
Net debt for FY2023 deducts KRW 0.08bn of short-term financial assets.
-
Total debt excludes trade payables.
Interim balance sheet, 30 June 2026 (KRW bn):
Source: [S4]. The June balance sheet reflects peak-season receivables from NH deliveries (KRW 64.0bn versus KRW 12.7bn at year-end) and inventory drawdown. These are normal seasonal swings, not a structural change.
Cash flow
Sources: OCF FY2021–FY2024 [S8]; FY2025 line items [S6]. Dividends and buybacks are shown as zero because no payments appear in aggregator cash-flow data and treasury stock is negligible (0.01%) [S6][S7]. Capex for FY2021–FY2024 was not available.
KRICT reports that Chobi invested more than KRW 10bn in new facilities for the bio-urethane CRF line [S14]. Construction-in-progress of KRW 2.15bn at end-2022 [S4] is consistent with that build-out being completed around 2022–23.
Ratio analysis
All ratios are analyst-computed from [S1], [S4] and [S5].
-
Net debt/EBITDA for FY2023 is not meaningful because EBITDA was negative.
-
Working-capital days use average year-end balances and are distorted by seasonality: December inventory is built ahead of spring.
-
Aggregator-reported ROE for FY2025 is 3.6%, consistent with the above [S1].
Commentary on trends, inflections and drivers
FY2021–FY2022: commodity windfall. Revenue rose 75.6% to KRW 148.6bn in FY2022 as global urea, ammonia and potash prices spiked after 2021 supply shocks and the 2022 Russia–Ukraine war. Chobi's periodic report showed average selling prices up 44% to 125% across key products in Q1 2022 [S9].
Gross margin fell slightly to 19.0%, but absolute gross profit rose 61%, lifting operating margin to 8.0%, the best in at least a decade [S1]. Cash flow did not keep pace. Operating cash flow was negative in both FY2021 (−KRW 8.0bn) and FY2022 (−KRW 13.7bn) as working capital ballooned at higher prices [S8].
FY2023: margin collapse. Revenue fell 22.8% and gross margin dropped to 9.5%. The company booked an operating loss of KRW 5.6bn and a net loss of KRW 9.0bn [S1].
Analyst interpretation: the pattern is consistent with high-cost raw-material inventory bought near the 2022 peak being sold into falling price resets in 2023. Larger Korean peer Namhae Chemical's operating profit fell 82% in the same year (KRW 62.6bn to KRW 11.1bn), which supports an industry-wide explanation [S24]. Inventories fell from KRW 55.7bn to KRW 46.1bn and operating cash flow turned positive (KRW 4.8bn) as working capital unwound [S4][S8].
FY2024–FY2025: normalisation at low profitability. Gross margin recovered to about 21%, in line with its 2016–2021 range of 20.8% to 24.7%. Revenue kept declining with lower nutrient prices, to KRW 102.4bn in FY2024 and KRW 99.7bn in FY2025 [S1].
Operating margin of 3.8% to 4.7% left little after interest expense of about KRW 2bn a year, so net margins were 0.6% to 2.0%. Retained earnings remain thin at KRW 7.8bn, which helps explain the absence of dividends.
1H26: second commodity upswing. The US–Iran conflict and disruption in the Strait of Hormuz pushed urea above US$700/t in April 2026, up 82.7% YoY [S22]. Q1 2026 revenue jumped 72.5% YoY, likely reflecting price resets and earlier ordering. Q2 2026 revenue then slipped 5.5% YoY and operating income fell 27.9%, suggesting input costs were rising faster than selling prices [S3].
Structural observations:
-
Funding. Operations are funded almost entirely by rolling short-term bank borrowings: KRW 43.3bn at end-2025, KRW 56.4bn at June 2026, and annual drawdowns and repayments above KRW 110bn [S4][S6].
-
Land. Land carried at KRW 33.7bn book value is about 62% of FY2025 equity. Its market value may differ materially, but no revaluation disclosure was reviewed [S4].
-
Low capital intensity. PP&E purchases of about KRW 2.6bn in FY2025 compare with depreciation of about KRW 1.8bn [S6].
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Revenue by Segment and Segment Margins & Growth (%)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Fertilizer segment revenue (KRW Bn) | 84.6 | 148.6 | 114.7 | 102.4 | 99.7 |
Segment revenue YoY growth (%) | 14.9 | 75.6 | -22.8 | -10.7 | -2.6 |
Segment operating income (KRW Bn) | 3.1 | 11.9 | -5.6 | 4.8 | 3.8 |
Segment operating margin (%) | 3.6 | 8.0 | -4.9 | 4.7 | 3.8 |
Share of total revenue (%) | 100 | 100 | 100 | 100 | 100 |
Revenue Lines
| Revenue line | Share of revenue, Q2 2026 (%) |
|---|---|
Fertilizer (manufactured products) | 88 |
Other | 8 |
Fertilizer (merchandise) | 4 |
Group Entities
| Entity | Relationship to Chobi | Stake | Notes |
|---|---|---|---|
Kyung Nong Corporation (KOSPI 002100) | Parent / largest shareholder | 54.56% | Crop-protection, seed, fertilizer and agri-solutions group; co-CEOs Lee Byung-man and Lee Yong-jin |
Leaders Chemical Co., Ltd. ((주)리더스케미컬) | Related party of the largest shareholder | 2.19% (end-2025) | Holding counted within the 56.75% group total |
Daeyu Co., Ltd. ((주)대유) | Investee | 9.67% | Compound-fertilizer producer; latest total assets about KRW 95.2bn, net profit about KRW 0.98bn |
Ulsan Broadcasting Corp. ((주)울산방송) | Investee | 4% | Regional broadcaster; latest total assets about KRW 105.8bn |
Pioneer Co., Ltd. ((주)파이오니아) | Investee | 6.1% | Dormant-scale entity (total assets about KRW 0.09bn) |
Income Statement and Per-Share Data
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Revenue (KRW Bn) | 84.6 | 148.6 | 114.7 | 102.4 | 99.7 |
Cost of sales (KRW Bn) | 67.0 | 120.3 | 103.8 | 81.2 | 78.8 |
Gross profit (KRW Bn) | 17.6 | 28.3 | 10.9 | 21.2 | 21.0 |
SG&A, derived as gross profit minus operating income (KRW Bn) | 14.5 | 16.4 | 16.5 | 16.4 | 17.2 |
Operating income (KRW Bn) | 3.1 | 11.9 | -5.6 | 4.8 | 3.8 |
EBITDA (KRW Bn) | 4.5 | 13.3 | -3.9 | 6.5 | 5.6 |
Depreciation and amortisation, derived (KRW Bn) | 1.4 | 1.4 | 1.7 | 1.7 | 1.8 |
Pre-tax income (KRW Bn) | — | — | — | — | 2.89 |
Income tax (KRW Bn) | — | — | — | — | 0.92 |
Net income (KRW Bn) | 1.9 | 8.6 | -9.0 | 0.6 | 2.0 |
EPS basic (KRW) | 357 | 1,664 | -1,741 | 123 | 380 |
EPS diluted (KRW) | 357 | 1,664 | -1,741 | 123 | 380 |
Dividend per share (KRW) | 0 | 0 | 0 | 0 | 0 |
Margin Analysis (%)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Gross margin (%) | 20.8 | 19.0 | 9.5 | 20.7 | 21.0 |
Operating margin (%) | 3.6 | 8.0 | -4.9 | 4.7 | 3.8 |
EBITDA margin (%) | 5.3 | 9.0 | -3.4 | 6.4 | 5.6 |
Net margin (%) | 2.2 | 5.8 | -7.9 | 0.6 | 2.0 |
Financial Analysis
| Line item | FY2025 |
|---|---|
Revenue | 99.73 |
Cost of sales | 78.75 |
of which raw materials | 74.77 |
of which labour (cost of sales) | 4.67 |
of which depreciation (cost of sales) | 1.53 |
Gross profit | 20.98 |
SG&A | 17.16 |
of which sales commissions | 5.76 |
of which freight | 3.55 |
of which salaries | 2.55 |
of which advertising | 1.51 |
of which fees and commissions | 1.25 |
of which R&D expense recognised in SG&A | 0.09 |
Operating income | 3.82 |
Finance income | 2.24 |
Finance costs | 3.67 |
of which interest expense | 1.96 |
of which FX transaction losses | 1.55 |
Pre-tax income | 2.89 |
Income tax | 0.92 |
Net income | 1.97 |
Income Statement
| Metric | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue (KRW Bn) | 26.8 | 52.2 | 11.8 | 11.6 | 25.3 | 49.1 | 11.3 | 14.0 | 43.6 | 46.4 |
Operating income (KRW Bn) | 2.2 | 4.4 | -1.3 | -0.4 | 1.8 | 5.3 | -2.6 | -0.7 | 4.7 | 3.8 |
Net income (KRW Bn) | 0.9 | 3.1 | -1.4 | -2.0 | 1.3 | 5.0 | -3.2 | -1.1 | 3.7 | 3.2 |
Balance Sheet and Per-Share Data
| Metric | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
Total assets (KRW Bn) | 130.0 | 118.6 | 119.9 | 123.3 |
Current assets (KRW Bn) | 78.1 | 67.4 | 70.3 | 70.6 |
Cash and equivalents (KRW Bn) | 0.49 | 1.33 | 5.35 | 4.38 |
Trade receivables (KRW Bn) | 18.7 | 16.7 | 11.3 | 12.2 |
Inventories (KRW Bn) | 55.7 | 46.1 | 50.7 | 52.2 |
Property, plant and equipment (KRW Bn) | 50.3 | 49.7 | 48.2 | 49.2 |
of which land at book value (KRW Bn) | 33.7 | 33.7 | 33.7 | 33.7 |
Goodwill and intangibles (KRW Bn) | 0.2 | 0.2 | 0.2 | 0.2 |
Current liabilities (KRW Bn) | 57.3 | 54.1 | 54.9 | 55.5 |
Short-term borrowings (KRW Bn) | 39.8 | 37.0 | 43.2 | 43.3 |
Current portion of long-term debt / lease (KRW Bn) | 0.17 | 0.19 | 0.19 | 0.15 |
Long-term financial liabilities (KRW Bn) | 0.26 | 0.20 | 0.16 | 0.12 |
Total debt (KRW Bn) | 40.2 | 37.4 | 43.6 | 43.6 |
Net debt (KRW Bn) | 39.7 | 35.9 | 38.2 | 39.2 |
Deferred tax liabilities (KRW Bn) | 4.4 | 6.1 | 5.9 | 6.8 |
Total liabilities (KRW Bn) | 68.6 | 66.3 | 67.2 | 68.6 |
Total equity (KRW Bn) | 61.5 | 52.3 | 52.7 | 54.7 |
Retained earnings (KRW Bn) | 14.2 | 5.2 | 5.8 | 7.8 |
Working capital (KRW Bn) | 20.8 | 13.4 | 15.4 | 15.1 |
Book value per share (KRW) | 11,841 | 10,070 | 10,145 | 10,534 |
Per-Share Data
| Item | 30 Jun 2026 |
|---|---|
Total assets | 149.6 |
Trade and other receivables | 64.0 |
Inventories | 28.8 |
Cash and equivalents | 3.6 |
Short-term borrowings | 56.4 |
Total liabilities | 87.9 |
Total equity | 61.7 |
Book value per share (KRW) | 11,884 |
Cash Flow
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Operating cash flow (KRW Bn) | -8.0 | -13.7 | 4.8 | -0.5 | 4.0 |
Capital expenditure, PP&E purchases (KRW Bn) | — | — | — | — | 2.65 |
Free cash flow, OCF minus capex (KRW Bn) | — | — | — | — | 1.4 |
Interest paid (KRW Bn) | — | — | — | — | 2.06 |
Dividends paid (KRW Bn) | 0 | 0 | 0 | 0 | 0 |
Share buybacks (KRW Bn) | 0 | 0 | 0 | 0 | 0 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Ratio | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
ROE, net income / year-end equity (%) | 14.1 | -17.3 | 1.2 | 3.6 |
ROA, net income / year-end assets (%) | 6.6 | -7.6 | 0.5 | 1.6 |
ROIC, NOPAT at 22% notional tax / (equity + net debt) (%) | 9.2 | -5.0 | 4.1 | 3.2 |
Current ratio (x) | 1.36 | 1.25 | 1.28 | 1.27 |
Total debt / equity (x) | 0.65 | 0.71 | 0.83 | 0.80 |
Total liabilities / equity (%) | 111.5 | 126.8 | 127.7 | 125.4 |
Net debt / EBITDA (x) | 3.0 | — | 5.9 | 7.0 |
Interest coverage, operating income / interest expense (x) | — | — | — | 1.9 |
Asset turnover, revenue / year-end assets (x) | 1.14 | 0.97 | 0.85 | 0.81 |
Days sales outstanding (days) | — | 56 | 50 | 43 |
Days inventory outstanding (days) | — | 179 | 218 | 239 |
Days payables outstanding (days) | — | 39 | 34 | 21 |
Cash conversion cycle (days) | — | 196 | 234 | 261 |
Revenue by Region and Region Margins & Growth (%)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Total revenue, predominantly South Korea (KRW Bn) | 84.6 | 148.6 | 114.7 | 102.4 | 99.7 |
Total revenue YoY growth (%) | 14.9 | 75.6 | -22.8 | -10.7 | -2.6 |
Capital Markets
| Item | Value |
|---|---|
Share price (16 Oct 2026) | About KRW 10,070 |
Market capitalisation | About KRW 52.3bn |
52-week range | KRW 9,080 to 17,450 (closing-price basis per [S1]); intraday high KRW 20,950 per [S10]/[S11] |
1-month return | −4.0% |
6-month return | −35.2% |
1-year return | −15.8% |
Return vs end-2023 close (KRW 14,000) | −28.1% (analyst-computed, about 2.8 years) |
Return vs end-2022 close (KRW 15,300) | −34.2% (analyst-computed, about 3.8 years) |
5-year return | Not computed (2021 price data not available in sources reviewed) |
Treasury shares | 0.01% |
Share Price and Market Valuation
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Year-end share price (KRW) | — | 15,300 | 14,000 | 10,500 | 11,780 |
Year-end market cap (KRW Bn) | — | 79.4 | 72.7 | 54.5 | 61.2 |
Year-end P/E (x) | — | 9.2 | — | 85.4 | 31.0 |
Year-end P/B (x) | — | 1.29 | 1.39 | 1.03 | 1.12 |
Dividend per share (KRW) | 0 | 0 | 0 | 0 | 0 |
Valuation Multiples
| Multiple | Basis | Value |
|---|---|---|
P/E | FY2025 EPS of KRW 380 | 26.5x |
P/E | TTM June 2026 EPS of KRW 493 | 20.4x |
P/B | FY2025 BPS of KRW 10,534 | 0.96x |
P/B | June 2026 BPS of KRW 11,884 | 0.85x |
EV | Market cap KRW 52.3bn + June 2026 net debt of about KRW 53.0bn | About KRW 105bn |
EV/EBITDA | TTM EBITDA of KRW 6.63bn ([S5] basis) | About 15.9x |
EV/EBITDA | FY2025 (EV using FY2025 net debt KRW 39.2bn; EBITDA KRW 5.6bn) | About 16.3x |
EV/Sales | TTM revenue of KRW 115.4bn | About 0.91x |
Debt Maturity Profile
| Maturity bucket (30 Jun 2026) | KRW Bn |
|---|---|
Short-term borrowings (≤ 1 year) | 56.4 |
Short-term financial liabilities | 0.12 |
Long-term financial liabilities (> 1 year; lease-type) | 0.06 |
Corporate bonds | 0.0 |
Analyst Conclusions
Management guidance and consensus
Management guidance: None issued.
Consensus growth expectations: None (no coverage).
Implied near-term trajectory (analyst view): 1H26 revenue was KRW 90.0bn (+21% YoY) and operating income KRW 8.5bn (+20%) [S3]. Q3–Q4 are seasonally loss-making: H2 2025 operating income was about −KRW 3.3bn. FY2026 revenue could therefore exceed FY2025's KRW 99.7bn, while full-year operating income depends heavily on H2 input costs and NH price resets. No numeric forecast is provided, consistent with the instruction not to estimate.
Bull-case arguments
-
Pricing tailwind from structurally higher nutrient prices. The World Bank's +31% fertilizer and +60% urea forecasts for 2026, and KREI's warning of instability through 2027, support higher NH price resets. Q1 2026 showed the upside: revenue +72.5% and operating income +158.6% [S23][S3].
-
Asset-backed downside. At about 0.85x June 2026 book value, with KRW 33.7bn of land on the balance sheet, the market capitalisation of about KRW 52bn sits close to tangible asset value [S4][S1].
-
Eco-CRF optionality. A commercialised biodegradable CRF platform (KRW 10.9bn of 2023 sales; KRICT and Aekyung partnerships; POSCO International export channel) gives a route to higher-margin specialty revenue if microplastic-related regulation or buyer preferences tighten [S14][S15][S16].
Bear-case arguments
-
Margin squeeze repeats 2023. Raw materials are about 95% of cost of sales [S5]. Q2 2026 operating income already fell 27.9% YoY on lower revenue [S3]. If NH price resets lag input inflation, the FY2023 pattern (9.5% gross margin, KRW 9.0bn net loss) could recur [S1].
-
Leverage and liquidity. Short-term borrowings rose to KRW 56.4bn by June 2026 against KRW 3.6bn of cash. Net debt/EBITDA reached 7.0x at FY2025 and interest coverage only 1.9x. Operating cash flow was negative in three of the last five years [S4][S5][S8].
-
Minority-shareholder disadvantages. No dividends, no buybacks and a controlling group that sold about 2.1 points of stake into the March 2026 spike. Most theme-driven gains reversed: the share price fell 35% over six months [S2][S1].
Key catalysts and monitorables (next 12 months)
| Timing | Catalyst / monitorable | Why it matters |
|---|---|---|
| By mid-Nov 2026 | Q3 2026 quarterly report | Size of the off-season loss; inventory valuation at higher input costs |
| Dec 2026 – Feb 2027 | NH Economic Holdings 2027 inorganic-fertilizer supply contract (single-contract disclosure if above threshold) | Volume and price base for FY2027 |
| Mar 2027 | FY2026 business report and AGM | Full-year margins, dividend decision, board changes |
| Ongoing | Urea, ammonia and DAP prices; Strait of Hormuz shipping status | Primary cost driver |
| Ongoing | KRW/USD | Import cost and FX losses |
| Ongoing | Largest-shareholder filings | Further stake sales or accumulation by Kyung Nong |
| Ongoing | Short-term borrowings and cash flow | Liquidity headroom |
| Ongoing | Biodegradable CRF sales and export orders | Evidence of specialty mix shift |
| Ongoing | Corporate value-up disclosures | No plan filed yet; a filing would signal a capital-return intent |
Concluding analyst verdict
Chobi Co., Ltd. is a seventy-year-old Korean compound-fertilizer maker with a credible but small franchise. It holds about 10% of a concentrated domestic market, has deep ties to the NH cooperative procurement system, owns four plants, and was early to biodegradable controlled-release fertilizer. These are real assets.
The financial record, however, shows a business that does not capture the value of its own commodity cycles. Over FY2021–FY2025, cumulative net income was about KRW 4.1bn and cumulative operating cash flow was negative. Net debt drifted up to about seven times EBITDA, and interest absorbs roughly half of operating profit in a normal year. The FY2022 windfall did not translate into a stronger balance sheet; it was largely reversed by the FY2023 loss.
The 2026 Middle East supply shock is the key test. The first quarter showed operating leverage to higher fertilizer prices. The second quarter showed the other side: input costs rising faster than NH price resets, with margins contracting.
For equity investors, the stock trades near book value with land backing, which limits downside on an asset basis. Upside appears to depend on three things:
-
whether NH pricing keeps pace with nutrient inflation through 2027;
-
whether eco-CRF products scale beyond a niche;
-
whether the controlling shareholder chooses to share value through dividends, buybacks or a value-up plan.
So far, the controlling group has sold into strength rather than signalled alignment with minorities.
Verdict: Chobi is best viewed as a cyclical, asset-backed micro-cap with event-driven trading characteristics, not a compounding business. An investment case requires evidence of sustained gross margin above about 20% under 2026–27 cost conditions, positive operating cash flow, deleveraging, and a first credible capital-return commitment. Absent those, the risk-reward is balanced to unfavourable, and position sizing should reflect very high volatility and low liquidity.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Executive Leadership Team
| Name | Title | Tenure | Compensation |
|---|---|---|---|
Lee Seung-yeon (이승연) | Representative Director (CEO) | — | Not individually disclosed (Korean rules require individual disclosure only above KRW 500m) |
Seo Yong-ho (서용호) | Head of Marketing Division | As of Nov 2023 | — |
“—” = not publicly disclosed.
Board & Management Changes
| Date | Event | Context |
|---|---|---|
23 Feb – 13 Mar 2026 | Largest-shareholder group stake falls from 56.65% to 54.56% across five DART filings | Coincided with the Hormuz-driven share-price spike to about KRW 20,000. |
26 Mar 2026 | Annual General Meeting results filed | — |
Major Shareholders
| Holder | Type | Stake (%) | As of |
|---|---|---|---|
Kyung Nong Corporation | Parent / strategic | 54.56 | End-2025 business report |
Leaders Chemical Co., Ltd. | Related party | 2.19 | End-2025 |
Largest-shareholder group, total | Strategic | 56.75 at end-2025; 54.56 per 13 Mar 2026 filing | — |
National Pension Service | Institutional | 0.24 | End-2024 |
Minority shareholders (8,950 holders) | Retail / other | About 43 | End-2025 |
Hedge funds | — | None identified | — |
Competitive Landscape
Key Competitors
| Competitor | Listing | Segment overlap | Latest revenue | Positioning vs Chobi | Source |
|---|---|---|---|---|---|
Namhae Chemical (남해화학) | KOSPI 025860 | Urea, compound fertilizers, chemicals; NH affiliate | KRW 1,604.4bn (FY2025, consolidated) | About 16× Chobi's revenue; NH ownership is a structural channel advantage | [S24] |
Farm Hannong (팜한농) | Unlisted (LG Chem subsidiary) | Crop protection, seeds, fertilizers incl. biodegradable CRF ("ecomula") | — | Direct competitor in eco-CRF with LG Chem backing | [S34] |
Nubo (누보) | KOSDAQ 332290 | CRF specialist; foaming-diffusion fertilizers | — | Technology-led CRF competitor with export traction | [S28] |
Hyosung ONB (효성오앤비) | KOSDAQ 097870 | Organic fertilizers, smart-farm nutrient products | KRW 22.0bn (FY ending June 2026) | Smaller; organic niche; higher margin | [S25] |
Daeyu (대유) | KOSDAQ | Compound fertilizers, organic and fertigation products | — | Chobi holds 9.67%; competitor and investee | [S2] |
KG Chemical (KG케미칼) | KOSPI | Fertilizer business within a diversified chemical group | Fertilizer revenue not disclosed in sources reviewed | Grouped with fertilizer stocks in Mar 2026 trading | [S21] |
Kyung Nong (경농) | KOSPI 002100 | Crop protection, seeds, fertilizers (consolidates Chobi) | KRW 325.2bn (latest annual, consolidated) | Parent rather than independent competitor; overlapping agri-input channel | [S26] |
Unid (유니드) | KOSPI | Potassium chemicals (potash derivatives) | — | Input-adjacent; traded as fertilizer-theme stock | [S21] |
Pungnong (풍농) | Unlisted | Compound fertilizers | — | — | — |
Global specialty-nutrient suppliers (e.g., ICL, Yara, Haifa) | Foreign-listed / private | Water-soluble and CRF specialty categories | Korean revenue not disclosed | — | Analyst characterisation |
“—” = not publicly disclosed.
Peer Comparison FY2025
| Metric | Chobi (FY2025) | Namhae Chemical (FY2025) | Hyosung ONB (FY Jun-2026) | Kyung Nong (latest annual, consolidated) |
|---|---|---|---|---|
Revenue (KRW Bn) | 99.7 | 1,604.4 | 22.0 | 325.2 |
Revenue growth YoY (%) | -2.6 | 5.6 | -9.9 | — |
Operating income (KRW Bn) | 3.8 | 43.1 | 2.4 | 26.7 |
Operating margin (%) | 3.8 | 2.7 | 10.9 | 8.2 |
Net income (KRW Bn) | 2.0 | 26.9 | 0.9 | 17.7 |
Net margin (%) | 2.0 | 1.7 | 4.1 | 5.4 |
R&D intensity (% of revenue) | 0.09 | — | — | — |
P/E (x, aggregator) | 26.5 | 24.7 | 43.7 | — |
P/B (x, aggregator) | 0.95 | 0.53 | 0.47 | — |
Market cap (KRW Bn, aggregator date) | 52.3 | 290.6 | 36.9 | — |



